Thomas Flachmeyer

Thomas Flachmeyer is an accomplished professional in the biotechnology and pharmaceutical industry, currently serving as an Independent Consultant at Emergent BioSolutions, where support is provided for Aseptic Fill/Finish issues raised by FDA warning letters. As the Director of cGMP Operations at MTF Biologics and President/CEO of Biotech Engineering Unlimited LLC, Thomas delivers technical support, process development, and regulatory advice, focusing on capital project execution and cost reduction. Previously, Thomas held various leadership roles, including Project Manager at BeiGene and Vice President at Prolong Pharmaceuticals, where responsibilities encompassed manufacturing, process development, and logistics. Thomas has a comprehensive educational background, including a Mini-MBA from Rutgers University and advanced degrees in Environmental Engineering from Stevens Institute of Technology and Syracuse University.